(Q53239923)

English

Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome.

scientific article published on 16 June 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

Rituximab and cyclosporine therapy for accelerated phase Chediak-Higashi syndrome. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Chikara Ogimi

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

Risa Tanaka

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

Takashi Arai

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

Akira Kikuchi

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

Ryoji Hanada

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

Tsutomu Oh-Ishi

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

publication date

16 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

57

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

677-680

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

The accelerated phase of Chediak-Higashi syndrome. An expression of the virus-associated hemophagocytic syndrome?

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Familial and acquired hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Modern management of children with haemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

The role of high dose methylprednisolone and splenectomy in the accelerated phase of Chédiak-Higashi syndrome

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Post-transplant lymphoproliferative disorders in children: the role of chemotherapy in the era of rituximab

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Successful treatment of virus-associated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Virus-associated haemophagocytic syndrome: further evidence for a T-cell mediated disorder

1 reference

https://api.crossref.org/works/10.1002%2FPBC.23231

21 January 2018

Identifiers

10.1002/PBC.23231

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21681939

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53239923&oldid=2155334400"